Primary pulmonary Hodgkin's lymphoma.

A 21-year-old man presented to hospital with a two-month history of productive cough with no other symptoms. Radiology revealed a cavitating lesion in the left upper lobe for which a variety of diagnoses were considered. A biopsy revealed primary pulmonary Hodgkin's lymphoma. Primary pulmonary Hodgkin's lymphoma is an uncommon initial presentation; lung lesions usually occur later in the course of the disease. Following diagnosis, the patient began chemotherapy and full remission was achieved.

Estudio descriptivo y abstinencia al año en una consulta de tabaquismo / Descriptive study and abstinence at one year of a smoking consultation

Objetivos: Estudio retrospectivo de datos procedentes de revisiónde historias clínicas, obteniendo: características demográficas y de tabaquismo,diferencias en función del género, abstinencia obtenida y predictoresde abstinencia.Pacientes y métodos: Se trata de una consulta individual basada enel tratamiento farmacológico y psicológico mínimo. A los pacientes seles realizó una anamnesis sobre antecedentes y tabaquismo, el test deFagerström, peso y CO en aire espirado. El seguimiento se realizó segúnel esquema propuesto por la SEPAR.Resultados: Sobre datos de 225 historias, la edad media fue de 47 ±10 años, siendo el 57% varones. El 7,4% no presentaba otras enfermedadesaparte del tabaquismo. La media del test de Fagerström, cigarrillos/día,paquetes año y CO fueron de 6,74 ± 2,10, 33,74 ± 15,77, 36,89 ± 20,23 y31,36 ± 15,91 respectivamente. Encontramos diferencias significativas enfunción del sexo en los paquetes-año (p = 0,009), CO (p = 0,004) y test deFagerström (p = 0,003). La abstinencia máxima se alcanzó a las tres semanasy fue del 83%, a los seis meses fue del 37% y al año del 28%.Conclusiones: Concluimos que consultan similar proporción de varonesy mujeres, en edad media, con enfermedades producidas por el tabacoy con alta dependencia a la nicotina; encontramos diferencias porgénero y obtenemos buenos resultados a corto plazo, aunque son menoresa seis meses y un año

Objectives: Retrospective study of data from clinical history review,obtaining: demographic and smoking characteristics, differences basedon gender, abstinence obtained and abstinence predictors.Patients and methods: This is an individual consultation based onminimum drug and psychological treatment. The patients wereadministered an anamnesis on background and smoking, the Fagerströmtest, weight and CO in exhaled air. Follow-up was done according to theSEPAR proposed schedule.Results: Based on data from 225 histories, mean age was 47 ± 10years, 57% being men. Atotal of 7.4% had no other diseases except forsmoking. The mean of the Fagerström test, cigarettes/day, packs per yearand CO were 6.74 ± 2.10, 33.74 ± 15.77, 36.89 ± 20.23 and 31.36 ±15.91 respectively. We found significant differences according to genderin packs-year (p = 0.009), CO (p = 0.004) and Fagerström test (p = 0.003).Maximum abstinence was reached at three weeks and was 83%. It was37% at six months and 28% at one year.Conclusions: We conclude that a similar proportion of consultationfrom men and women who are middle aged, with diseases producedby tobacco and with high dependence to nicotine. We found differencesby gender and obtained good short-term results, although they are lessat six months and one year

[Pulmonary metastases of malignant melanoma. A rare endobronchial presentation]. / Metástasis pulmonares de melanoma maligno. Presentación infrecuente endobronquial.

Malignant melanoma has a tendency to metastasize to the lung in the course of tumor growth. Many such cases have been described in the literature, although cases of endobronchial metastasis of this type of tumor revealed during fiberoptic bronchoscopy are difficult to find. We report three cases of extension of the primary tumor to the lung, diagnosed by fiberoptic bronchoscopy during which biopsy specimens were obtained. After tissue inspection, the initial suspicion of metastasis of malignant melanoma was confirmed. We review the prevalence, radiologic presentation, prognosis and treatment options for this type of metastasis.